Miyako Capital
Venture capitalKyoto · Pre-Seed–Growth · 5 people tracked
Also known as みやこキャピタル株式会社
Investment thesis
As an independent private VC and designated collaboration-fund operator for Kyoto University, Miyako Capital invests in technology-development ventures that build on advanced intellectual assets from Kyoto University and other academic and research institutions. Beyond capital, the firm supports growth through industry-academia collaboration aimed at bringing technology into real-world use, seeking to create the leading industries and innovation of the next generation. Its team has particular depth in life sciences and biotech, including drug discovery and medical devices, and supports academia-born startups from commercialization through exit, including global expansion via its Silicon Valley presence.
Source: firm website, verified Aug 7, 2026.
Team · 5 people
from the firm's websiteWhat they invest in
from 39 of 44 portfolio companiesBiotech ×11AI & Machine Learning ×10Deep Tech ×10Hardware ×9Medical Devices ×7Cleantech ×5Enterprise Software ×5Healthtech ×5
HQs:Japan×27United States×6United Kingdom×1
Who they back
founder profiles across 16 portfolio companiesFounding team size:solo founder×82 founders×53 founders×24+ founders×1
Investments · 44 tracked
founders shown can be your intro pathBy year:2021 · 12016 · 12 dated
LINK-US Co., Ltd. develops, designs, and manufactures devices based on ultrasonic complex vibration and high-power ultrasonic technology, including room-temperature bonding equipment for joining same and dissimilar metal materials.
Advanced ManufacturingDeep TechHardwareTokyo, JP
Jun Mitsuyuki(Representative Director)
Co-investorsShizuoka CapitalKepple GroupMitsubishi UFJ CapitalMizuho CapitalSMBC Venture CapitalSumitomo Mitsui Trust nvestment Co. Ltd.
RegImmune develops immune-modulation therapies that use regulatory T cells to induce immune tolerance or to trigger anti-tumor immune responses.
Biotech
Co-investorsDBJ CapitalHiroshima Venture Capital Co. Ltd.Oita Venture Capital
PR TIMES is a press release distribution service that helps companies distribute news releases to media and the public, with content syndicated across more than 260 partner sites.
Marketing TechMedia & EntertainmentSaaS
Co-investorsAngel Bridge Co.,Ltd.basepartnersDD Holdings Venture CapitalDIMENSIONi Cubed Venturesi-nest capital+7 more
ALGO ARTIS builds optimization algorithms and AI that model real-world operational constraints to improve enterprise planning tasks across demand, procurement, production, and operations.
Advanced ManufacturingAI & Machine LearningEnterprise Software
Co-investorsDIMENSIONDRONE FUNDSony Ventures CorporationUTEC
Drivemode builds vehicle companion apps and in-vehicle software platforms for Honda and Acura cars and electric motorcycles, including connected apps like Honda RoadSync and the Drivemode Android app.
IoTMobility & TransportationSaaSSan Jose, US
Yokichi Koga(Executive Officer, Director)Yo Koga(CEO)
Co-investorsHonda Innovations Silicon Valley
EX-Fusion is a Japanese private company developing laser-based nuclear fusion energy technology, aiming to decarbonize existing energy sources and contribute to carbon neutrality.
CleantechDeep TechEnergyKyoto, JP
Kazuki Matsuo(代表取締役社長 (President & CEO))
Co-investorsDelight VenturesMPowerOSAKA University Venture CapitalShizuoka Capital
Floadia develops and licenses non-volatile embedded memory IP, including manufacturing process technology and circuit designs, to semiconductor makers and foundries.
AI & Machine LearningDeep TechHardwareSemiconductorsKodaira, JP
Kosuke Okuyama(President & CEO)
Co-investorsTEL Venture Capital, Inc.UMC CapitalUntroD Capital
Galderia develops technology based on extremophile microalgae, including algae-derived bioadsorbents used for recovering trace metals such as palladium.
BiotechCircular EconomyCleantech
Tanimoto(Representative)
Goryo Chemical develops fluorescence-based technology to visualize diseases and support diagnosis and treatment.
BiotechHealthtechMedical DevicesNew MaterialsTokyo, JP
Co-investorsDG IncubationS VenturesUniversal Materials Incubator
Hephas Energy develops environmentally friendly technologies and digital transformation tools aimed at supporting smart city initiatives and sustainable development.
CleantechClimate TechEnergy
IGS (Institution for a Global Society) provides AI-powered assessment tools that measure competencies, temperament, and non-cognitive skills of employees, job candidates, and students, visualizing capabilities for companies and educational institutions.
AI & Machine LearningEdTechHR Tech
iHeart Japan is a regenerative medicine company developing cell-therapy products for the heart using iPS (induced pluripotent stem) cells, aiming to provide new treatment options for heart disease.
BiotechLongevityMedical Devices
Co-investorsUntroD Capital
Liqid provides composable infrastructure software and hardware that lets datacenters disaggregate servers and dynamically allocate accelerators such as GPUs across resources to match specific workloads.
Cloud ComputingData & InfrastructureEnterprise SoftwareHardwareWestminster, US
Jason Breakstone(Executive Officer, Director)Sumit Puri(Founder)inJim Antes(Executive Officer)Bryan Schramm(Executive Officer)Edgar Masri(Executive Officer, Director)in
BoardRyan Pollock(Director)in
Co-investorsChartline Capital Partners
LocationMind provides location intelligence and spatial analysis services using GNSS positioning, satellite imagery, IoT sensing (LiDAR, UWB), and mobile big data to support urban planning, infrastructure, mobility, and commercial applications across multiple sectors.
AI & Machine LearningData & InfrastructureIoTTokyo, JP
Naoki Kiritani(Founder / CEO)Ryosuke Shibasaki(Founder / CTO)Dinesh Manandhar(Founder / CDO)
Co-investorsFunds StartupsHulic StartupShizuoka CapitalZENRIN FUTURE PARTNERS
Megakaryon is a Japanese regenerative-medicine venture developing platelet products derived from human iPS cells, including HLA-homozygous iPS-cell-derived platelets (MEG-002) that have advanced into clinical trials.
BiotechLongevityMedical Devices
mui Lab designs and manufactures calm technology interfaces and IoT systems that integrate natural materials with digital touchpoints for smart home and wellness applications.
ConsumerHardwareIoTSaaSKyoto-shi, JP
Kazunori Oki(Co-founder & CEO)in
Co-investorsMonozukuri VenturesTechstars
Oishii operates indoor vertical farms that grow premium produce including its Omakase Berry strawberries and Rubī Tomato, sold direct to consumers and through retail partners like Whole Foods.
AgTechDirect to ConsumerFoodTech
Hiroki Koga(Co-founder)inBrendan Somerville(Co-founder)
Co-investorsBloom8Grit VenturesMcWin Capital PartnersMobile Internet Capital, Inc.Sony Ventures Corporation
Orange develops a batch localization tool for manga and is building emaqi, a manga e-bookstore service planned to launch in the US in 2024.
AI & Machine LearningConsumerMedia & Entertainment
Co-investorsGlobis Capital Partners
Peds3 (Pediatrics 3.0) is a "kids DoTank" focused on the future of pediatric medicine, aiming to implement biopsychosocial care for children using digital tools and evidence.
Digital HealthHealthtech
Pentalink develops a fully automated, sterile sericulture (silkworm farming) system using robotics, ICT, and IoT, along with production of sterile dried mulberry-leaf powder for artificial silkworm feed.
BiotechNew MaterialsRobotics
Pocketalk makes an AI-powered handheld translation device for one-on-one conversations and "Sentio," an AI simultaneous interpretation service for one-to-many real-time interpreting across events, schools, retail, and government settings.
AI & Machine LearningEdTechHardware
Co-investorsDIMENSION
Sakana AI develops frontier AI research and products, including large language models, multi-agent orchestration systems, and AI solutions tailored for Japanese enterprises and public sector organizations.
AI & Machine LearningCloud ComputingDeep TechDefense TechTokyo, JP
David Ha(Co-Founder & CEO)Ren Ito(Co-Founder & Chairman)inLlion Jones(Co-Founder & CTO)AI FujikiYuta Tamaru
Co-investorsGlobal BrainBasis Set VenturesIn-Q-Tel500 GlobalFujitsu VenturesGeodesic Capital+11 more
SFG Sciences is a drug discovery and development company focused on creating breakthrough therapeutics across various diseases.
Biotech
Board上村 尚人エイミー・ブロイドリック
Co-investorsVision Incubate
SocialGood offers a shopping cash-back service and browser extension covering over 20,000 stores, where users earn rewards in the platform's SG cryptocurrency.
ConsumerCrypto & Web3E-commerce
Japanese company that plans, develops, and sells IT products.
Enterprise SoftwareSaaSTokyo, JP
高嶋 晃(代表取締役 (CEO))
Co-investorsMonozukuri Ventures
UltraSolar Technology develops QuantumBoost (QB), a hardware device that increases the power output of photovoltaic modules by over 10% and lowers the levelized cost of energy for solar farm owners and operators.
CleantechEnergyHardwareSanta Clara, US
Santosh Kumar(Executive Officer, Director)Rob Soni(Director)Rahul Chopra(Director)
BoardYsunesaburo Sugaya(Director)
Varinos develops and provides genetic testing services applying genome technology, including a uterine microbiome (endometrial flora) test used in fertility and reproductive medicine.
BiotechDigital HealthFemTechMedical DevicesTokyo, JP
桜庭 喜行(Founder & Chairman (former CEO))長井 陽子(Co-founder)Sakuraba(CEO)Yoshiyuki Sakuraba(Founder)inYoko Nagai(Founder)in齊藤 洋一(代表取締役CEO)
Co-investorsAngel Bridge Co.,Ltd.Fast Track InitiativeMIRAI SOUZOUSony Ventures Corporation
Viage Therapeutics is a neuroscience drug developer working on novel oral neurotherapeutics that target the gut-brain axis, including its lead clinical candidate DGX-001 for cognitive impairment in conditions such as Alzheimer's and Parkinson's disease.
BiotechDeep TechHealthtechSan Francisco Bay Area, US
Titus Plattel(Leadership Team)inBrian Rogers(Leadership Team)inNeil Schwartz(Leadership Team)inSujata Sankar(Leadership Team)inSteven King(Leadership Team)in
Co-investorsKyoto University Innovation CapitalRDiscoveryRemiges Ventures, Inc.
VividQ develops computer-generated holography (CGH) software and technology for 3D holographic displays, with an early focus on AR and VR gaming applications.
Deep TechGamingHardware
Co-investorsUTokyo Innovation Platform Co. Ltd.
Startbahn provides Startrail, a blockchain-based platform for the art market that records the provenance, authenticity, and ownership history of artworks, using NFC tags and NFTs to verify pieces and enable resale royalties for creators.
Crypto & Web3Media & EntertainmentSaaS
Co-investorsSX Capital, Inc.TBS Innovation Partners
Co-investorsAngel Bridge Co.,Ltd.Beyond Next VenturesUniversal Materials Incubator
Sukutachi is a mobile app that connects construction businesses and craftspeople to discover work opportunities and expand their professional networks.
Construction TechMarketplaces
Co-investorsANOBAKAJapan Post Capital Co. Ltd.MPowerGenesia Ventures
Innovative Space Carrier (将来宇宙輸送システム株式会社) is a Japanese company developing future space transportation systems.
Deep TechHardwareLogistics & Supply ChainSpace TechTokyo, JP
畑田 (Hatakuta)(CEO)畑田 康二郎(代表取締役社長 兼 最高経営責任者 (CEO))野村 (Nomura)(COO)
Co-investorsAngel Bridge Co.,Ltd.Dentsu VenturesXTech Ventures
Co-investorsShizuoka CapitalX-HUB TOKYO Global Startup AcceleratorEnergy & Environment Investment
FLOSFIA develops power semiconductor devices based on corundum-structure gallium oxide (α-Ga₂O₃), a material originating from Kyoto University in Japan, using its proprietary water-based "MISTEPITAXY" mist deposition process to achieve lower loss than SiC at silicon-level cost.
CleantechDeep TechNew MaterialsSemiconductorsKyoto, JP
人羅俊実(創業者・取締役会長 (Founder & Chairman))四戸孝(代表取締役社長 (President & CEO))
Co-investorsKyoto University Innovation CapitalUTECEnergy & Environment Investment
Ai-BrainScience Inc. is a Japanese company holding a Type 2 medical device manufacturing and sales license.
AI & Machine LearningDigital HealthHealthtechMedical DevicesSuita, JP
森下 竜一(取締役会長 (Chairman))髙村 健太郎(代表取締役社長 (President & CEO))
Board北嶋 学(取締役 (Director))
Co-investorsNippon Venture CapitalOSAKA University Venture Capital
StemRIM is a biopharmaceutical company developing regenerative medicine therapies.
BiotechHealthtechMedical Devices
Co-investorsNippon Venture CapitalSMBC Venture Capital
Kyoto Drug develops novel therapeutic drugs for rare and difficult-to-treat ocular diseases including retinal artery occlusion and retinitis pigmentosa, using a new small-molecule compound (KUS agent) based on research from Kyoto University.
BiotechMedical DevicesKyoto, JP
Musashi (武蔵)(CEO)
Co-investorsKyoto University Innovation Capital
Portfolio news
latest coverage across their companies
Teams · bioengineer.org · Aug 19, 2026
Sakana AI · sakana.ai · Nov 17, 2025
Frequently asked questions
- How many investments has Miyako Capital made?
- Miyako Capital has 44 tracked investments.
- What stage does Miyako Capital invest at?
- Miyako Capital invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
- What sectors does Miyako Capital focus on?
- Miyako Capital focuses on Biotech, Deep Tech, Energy, Healthtech, Medical Devices, Sector Agnostic.
- Where is Miyako Capital located?
- Miyako Capital is headquartered in Kyoto, JP.
- Who does Miyako Capital co-invest with?
- Miyako Capital most often shares deals with Angel Bridge Co.,Ltd., Shizuoka Capital, DIMENSION, among 67 tracked co-investors.
Images
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Oxford Science Enterprises (OSE) is an investment company that funds and scales spinouts arising from research at Oxford, Harwell and Culham, partnering with researchers to co-create ventures across deep tech, life sciences and healthtech.
MaRS is a Toronto-based innovation hub and accelerator that supports Canadian startups from pre-seed funding through international expansion, offering workspace, mentorship, investor and customer connections, and sector-focused programming.
Ontario Centre of Innovation (OCI) is a government-supported organization that funds and supports innovation, academic-industry collaboration, and commercialization of technologies among Ontario companies.